$3.85B
$107,000
0.0% of portfolio
2,793
Q3 2025
Added 0.04%
$1.26B
$311,000
0.0% of portfolio
11,600
Q2 2025
Added 7.41%
$9.71B
$274,000
0.0% of portfolio
3,696
Q3 2025
Added 0.05%
-
$0
0.0% of portfolio
-
Q2 2025
New
$1.43B
$775,000
0.0% of portfolio
45,100
Q3 2025
Added 4.88%
-
$0
0.0% of portfolio
-
Q3 2025
Added 15.54%
$363M
$447,000
0.0% of portfolio
102,900
Q2 2025
Added 7.64%
$267M
$543,000
0.0% of portfolio
8,000
Q3 2025
Reduced 8.05%
$159M
$27,000
0.0% of portfolio
1,300
Q1 2024
Reduced 7.14%
$72.8M
$13,000
0.0% of portfolio
1,100
Q2 2024
New
$720M
$30,000
0.0% of portfolio
2,600
Q2 2025
New
$2.16B
$351,000
0.0% of portfolio
34,600
Q3 2025
Reduced 4.95%
-
$0
0.0% of portfolio
-
Q3 2024
New
$148M
$333,000
0.0% of portfolio
31,400
Q2 2025
Added 7.53%
$2.41B
$501,000
0.0% of portfolio
10,500
Q2 2025
Reduced 4.55%
$1.98B
$185,000
0.0% of portfolio
4,200
Q3 2025
Reduced 68.89%
$149K
$601,000
0.0% of portfolio
41,500
Q3 2025
Added 7.79%
$4.11B
$181,000
0.0% of portfolio
3,162
Q3 2025
Added 2.16%
$39.1B
$1.13 Million
0.0% of portfolio
4,356
Q3 2025
Reduced 61.07%
$3.54B
$686,000
0.0% of portfolio
20,300
Q3 2025
Reduced 3.79%
$24.5B
$559,000
0.0% of portfolio
4,945
Q3 2025
Reduced 72.91%
$436M
$65,000
0.0% of portfolio
4,100
Q1 2024
Reduced 6.82%
$4.08B
$1.17 Million
0.0% of portfolio
29,700
Q2 2025
Added 3.13%
$26.6B
$529,000
0.0% of portfolio
3,845
Q3 2025
Added 0.03%
$3.1B
$87,000
0.0% of portfolio
1,700
Q3 2025
Reduced 15.0%
$17.1B
$358,000
0.0% of portfolio
4,247
Q3 2025
Reduced 85.23%
$5.3B
$126,000
0.0% of portfolio
1,217
Q2 2025
Reduced 93.29%
$275M
$36,000
0.0% of portfolio
1,100
Q3 2024
New
$5.56B
$112,000
0.0% of portfolio
1,495
Q3 2025
Reduced 93.38%
$994M
$821,000
0.0% of portfolio
38,200
Q3 2025
Added 235.09%
$11.6B
$1.31 Million
0.0% of portfolio
35,801
Q3 2025
Reduced 38.11%
$14.8B
$322,000
0.0% of portfolio
2,336
Q3 2025
Reduced 1.18%
Tonix Pharmaceuticals Holdin
-
$0
0.0% of portfolio
-
Q3 2025
Added 153.57%
$1.59B
$142,000
0.0% of portfolio
3,400
Q3 2025
New
$7.32B
$179,000
0.0% of portfolio
2,357
Q3 2025
Reduced 1.09%
$6.15B
$722,000
0.0% of portfolio
12,712
Q3 2025
Added 0.04%
$390M
$13,000
0.0% of portfolio
300
Q2 2022
New
$5.12B
$87,000
0.0% of portfolio
1,468
Q3 2025
Reduced 2.26%
$283M
$395,000
0.0% of portfolio
49,300
Q3 2025
Reduced 14.56%
$1.52B
$13,000
0.0% of portfolio
300
Q1 2025
New
$3.47B
$86,000
0.0% of portfolio
1,300
Q2 2025
Reduced 71.11%
$764M
$566,000
0.0% of portfolio
15,600
Q2 2025
Added 7.59%
-
$0
0.0% of portfolio
-
Q2 2025
New
$3.03B
$1.04 Million
0.0% of portfolio
15,900
Q3 2025
Reduced 14.97%
$7.29B
$171,000
0.0% of portfolio
5,142
Q3 2025
Reduced 92.58%
$729M
$477,000
0.0% of portfolio
68,100
Q2 2025
Added 196.09%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 52.39%
$855M
$22,000
0.0% of portfolio
4,515
Q3 2025
Reduced 97.22%
$1.01B
$21,000
0.0% of portfolio
4,408
Q3 2025
Reduced 1.76%
$2.43B
$886,000
0.0% of portfolio
5,300
Q2 2025
Added 8.16%